Skip to content

13F-HR filed by Atle Fund Management AB

Atle Fund Management AB filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-10-21, with 10 holding rows worth $47,342,000.

Accession
0001381843-22-000010
Filed
2022-10-21
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 10 entries on the cover page, a total value of $47,342,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $47,342,000 with VALUE read as thousands by filing date, 13F file number 028-12171. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
UTAH MEDICAL PRODUCTS INC917488108COMMON STOCK86,000$7,337,000thousands by filing date
Bristol-Myers Squibb Company110122108COM98,000$6,967,000thousands by filing date
Gilead Sciences,Inc.375558103COM105,000$6,477,000thousands by filing date
Cigna Corporation125523100COM17,000$4,717,000thousands by filing date
ZEVRA THERAPEUTICS INC COM NEW488445206Stock750,000$4,680,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM70,000$4,668,000thousands by filing date
MCKESSON CORP COM58155Q103Stock13,000$4,418,000thousands by filing date
VIATRIS INC COM92556V106Stock480,000$4,090,000thousands by filing date
OPIANT PHARMACEUTICALS INC683750103COM210,000$2,258,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock230,000$1,730,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001381843-22-000010this filing2022-10-21acceptance time not in the bulk data set